GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » Buyback Yield %

Sartorius AG (Sartorius AG) Buyback Yield % : -1.14 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Sartorius AG's current buyback yield was -1.14%.


Sartorius AG Buyback Yield % Historical Data

The historical data trend for Sartorius AG's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Buyback Yield % Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -4.20

Competitive Comparison of Sartorius AG's Buyback Yield %

For the Medical Instruments & Supplies subindustry, Sartorius AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Buyback Yield % falls into.



Sartorius AG Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Sartorius AG's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 19503.00688
=0.00%

Sartorius AG's annualized Buyback Yield for the quarter that ended in Mar. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (215.652 + 0) * 4 / 20522.49468
=-4.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Mar. 2024) data.


Sartorius AG Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (Sartorius AG) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG (Sartorius AG) Headlines

From GuruFocus

Resolutions of the Supervisory Board of Sartorius AG

By PRNewswire PRNewswire 02-11-2021

Sartorius to expand Business Operations in North America

By PRNewswire PRNewswire 09-27-2021

Change in Composition of Sartorius Joint Heirship

By PRNewswire PRNewswire 10-13-2021

Sartorius with first-quarter uptick in sales and earnings

By PRNewswire PRNewswire 04-21-2021

Sartorius To Join The DAX Blue Chip Index

By PRNewswire PRNewswire 09-04-2021

Sartorius with continued growth in a challenging environment

By PRNewswire PRNewswire 10-19-2022

Sartorius significantly expands activities in South Korea

By PRNewswire PRNewswire 11-25-2021